121 related articles for article (PubMed ID: 27872746)
1. A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms.
Pathak KA; Goertzen AL; Nason RW; Klonisch T; Leslie WD
Ann Med Surg (Lond); 2016 Dec; 12():27-31. PubMed ID: 27872746
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET characteristics of Hürthle cell and follicular adenomas.
Pathak KA; Klonisch T; Nason RW; Leslie WD
Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
[TBL] [Abstract][Full Text] [Related]
3. Quantitative classification and radiomics of [
de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
[TBL] [Abstract][Full Text] [Related]
4. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
Merten MM; Castro MR; Zhang J; Durski J; Ryder M
Thyroid; 2017 Jan; 27(1):95-102. PubMed ID: 27762671
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of malignant thyroid lesions on [
Nasr H; Farghaly H; Alqarni A; Al-Salem S; Sayed M
Eur J Radiol Open; 2021; 8():100373. PubMed ID: 34458507
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Significance of Incidental Focal Thyroid Uptake on (18)F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom.
Agrawal K; Weaver J; Ul-Hassan F; Jeannon JP; Simo R; Carroll P; Hubbard JG; Chandra A; Mohan HK
Eur Thyroid J; 2015 Jun; 4(2):115-22. PubMed ID: 26279997
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.
Kim JM; Ryu JS; Kim TY; Kim WB; Kwon GY; Gong G; Moon DH; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2007 May; 92(5):1630-4. PubMed ID: 17284624
[TBL] [Abstract][Full Text] [Related]
8. [
de Koster EJ; de Geus-Oei LF; Brouwers AH; van Dam EWCM; Dijkhorst-Oei LT; van Engen-van Grunsven ACH; van den Hout WB; Klooker TK; Netea-Maier RT; Snel M; Oyen WJG; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1970-1984. PubMed ID: 34981165
[TBL] [Abstract][Full Text] [Related]
9. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
Ladrón de Guevara H D; Munizaga M C; García S N; Letelier B C; Wash F A
Rev Med Chil; 2020 Jan; 148(1):10-16. PubMed ID: 32730431
[TBL] [Abstract][Full Text] [Related]
11.
Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
[TBL] [Abstract][Full Text] [Related]
12. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
[TBL] [Abstract][Full Text] [Related]
13. Elastosonography scoring and strain index of thyroid nodules with Hurthle cells.
Tuzun D; Ersoy R; Kilicyazgan A; Kiyak G; Yalcin S; Cakir B
Minerva Endocrinol; 2016 Jun; 41(2):157-65. PubMed ID: 25310014
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
17. Hürthle Cells on Fine-Needle Aspiration Cytology Are Important for Risk Assessment of Focally PET/CT FDG Avid Thyroid Nodules.
Poller DN; Megadmi H; Ward MJA; Trimboli P
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260994
[TBL] [Abstract][Full Text] [Related]
18. Improving diagnostic performance of
Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
[TBL] [Abstract][Full Text] [Related]
19. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
Giovanella L; Suriano S; Maffioli M; Ceriani L
Clin Endocrinol (Oxf); 2011 May; 74(5):644-8. PubMed ID: 21470288
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
